MTOR and renal carcinoma: In‐depth research on the regulatory mechanisms of the PI3K/AKT/mTOR pathway in renal cancer holds immense potential in elucidating the molecular pathological mechanisms of renal cancer and developing new therapeutic strategies and drug targets.